Manufacturing

The movement toward off-the-shelf immunotherapy is solving the scalability issues that have long limited the reach of personalized autologous cellular treatments in oncology clinics. While chimeric antigen receptor (CAR) T-cell therapies have established a foundational success in treating

Disconnected development environments often lead to inconsistent patching across different product variants, creating dangerous gaps in device security. As medical devices evolve into complex, software-defined ecosystems, the traditional boundaries between hardware and digital connectivity have

The Joint Steering Committee oversees a research pipeline that allows for the rapid pivot toward new health threats as they emerge in the Southern Hemisphere landscape. This strategic collaboration between Moderna and CSIRO establishes a robust biosecurity framework intended to fortify Australia’s

With BD products being used in ninety percent of U.S. hospital visits, the company's move to solidify domestic production is a cornerstone of national health security. For decades, the globalized medical supply chain prioritized cost efficiency over redundancy, leaving healthcare providers

A comparative study using a trastuzumab biosimilar revealed that automation can reduce the average variability in glycan profiling by twenty-eight percent compared to manual processing. This discovery comes at a critical time in 2026, as the pharmaceutical sector grapples with the increasing

BeneMeat’s partnership with the Italian brand FORZA10 serves as a practical case study for the commercial application of cultivated cells in the animal feed sector. This collaboration marks a significant milestone in the broader trajectory of cellular agriculture, moving beyond speculative research